Pittsburgh, Pennsylvania 15213

  • Cognitive Behavioral Therapy


The study includes participants experiencing distress with regard to stopping immunotherapy and will utilize cognitive-behavioral therapy to reduce fear of recurrence, depression, and anxiety and improve quality of life.

Study summary:

The intervention will be delivered through telemedicine to reduce the patient-related barriers to treatment including cost, transportation, and being able to maintain appointments while managing the side effects of treatment. The intervention will provide the patient with skills to reduce distress associated with ceasing treatment of a checkpoint inhibitor through the development evidence-based psychological and behavioral strategies that are tailored to the patients' preferences.


Inclusion Criteria: - Age 21 years and older - Fluent in English - Diagnosis of cancer and history of treatment with immunotherapy Exclusion Criteria: - Active suicidal ideation, delusions or hallucinations



Primary Contact:

Jennifer L Steel, Ph.D.
Phone: 412-692-2041
Email: steejl@upmc.edu

Backup Contact:


Location Contact:

Pittsburgh, Pennsylvania 15213
United States

Jennifer L Steel, Ph.D.
Phone: 412-692-2041
Email: steejl@upmc.edu

Site Status: Recruiting

Data Source: ClinicalTrials.gov

Date Processed: June 12, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.